4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001193125-26-268202
Director sold 572 shares at an average $247.65 ($141,656)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| JEFFS ROGER Director | 2026-06-10 | Sale 10b5-1 | −286 | $246.18 | $70,407 | 58,653 | D: show line 1 in the form |
| JEFFS ROGER Director | 2026-06-11 | Sale 10b5-1 | −286 | $249.12 | $71,248 | 58,367 | D: show line 2 in the form |
| Open-market sales · 572 sh · avg $247.65 · $141,656 | |||||||
Loading xslF345X06/ownership.xml…